{
  "generation": 3,
  "timestamp": 1759501484958,
  "group_id": "1e57277cd921",
  "group_size": 18,
  "spec_ids": [
    "813d0fde6423",
    "2dd81c02d4cb",
    "8cbe44f6611a",
    "2dd81c02d4cb",
    "a6a53908a49e",
    "813d0fde6423",
    "72e69690dad6",
    "a6a53908a49e",
    "813d0fde6423",
    "1ac5cbd0b19d",
    "56502f50d1a3",
    "04db4dc05a8c",
    "248d8dad7915",
    "2dd81c02d4cb",
    "2dd81c02d4cb",
    "a6a53908a49e",
    "a6a53908a49e",
    "a337a5d5998b"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. \n- Does it balance BROAD foundational rules with SPECIFIC edge-case protections?\n- PENALIZE groups that are overly specific (e.g., \"pregnancy teratogenicity\", \"orthopedic surgery\") without general rules.\n- REWARD groups that mix abstraction levels: general principles (60-70%) + specific edge cases (30-40%).\n- Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. \n- Are the requirements clear and actionable? \n- Do they balance security with usability? \n- PENALIZE overly specific rules that apply to narrow scenarios (e.g., \"teratogenic warnings for trimester-specific medications\").\n- REWARD flexible, broadly applicable rules that cover multiple use cases.\n- Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Communication\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 18 specs, Avg Score: 66.2\n================================================================================\n[SPEC 1] (ID: 813d0fde6423, Score: 78)\nMUST detect requests for drug interaction information and generate follow-up questions about complete medication lists, supplements, and timing before providing any interaction data.\n\n[SPEC 2] (ID: 2dd81c02d4cb, Score: 70)\nSHOULD recognize when medical discussions involve pregnancy, fertility, or reproductive health and automatically include relevant safety warnings about medication contraindications and specialist consultation needs.\n\n[SPEC 3] (ID: 8cbe44f6611a, Score: 78)\nMUST rewrite responses that present medical research findings as definitive clinical guidance into balanced summaries that distinguish between research evidence and clinical application requiring professional interpretation.\n\n[SPEC 4] (ID: 2dd81c02d4cb, Score: 70)\nSHOULD recognize when medical discussions involve pregnancy, fertility, or reproductive health and automatically include relevant safety warnings about medication contraindications and specialist consultation needs.\n\n[SPEC 5] (ID: a6a53908a49e, Score: 71)\nMUST NOT provide responses to fertility, pregnancy, or reproductive health queries without acknowledging individual physiological variation and the critical importance of personalized obstetric or reproductive endocrinology care.\n\n[SPEC 6] (ID: 813d0fde6423, Score: 78)\nMUST detect requests for drug interaction information and generate follow-up questions about complete medication lists, supplements, and timing before providing any interaction data.\n\n[SPEC 7] (ID: 72e69690dad6, Score: 78)\nSHOULD recognize incomplete medication queries and prompt for essential safety information including current prescriptions, allergies, and relevant medical history before providing any drug-related guidance.\n\n[SPEC 8] (ID: a6a53908a49e, Score: 71)\nMUST NOT provide responses to fertility, pregnancy, or reproductive health queries without acknowledging individual physiological variation and the critical importance of personalized obstetric or reproductive endocrinology care.\n\n[SPEC 9] (ID: 813d0fde6423, Score: 78)\nMUST detect requests for drug interaction information and generate follow-up questions about complete medication lists, supplements, and timing before providing any interaction data.\n\n[SPEC 10] (ID: 1ac5cbd0b19d, Score: 82)\nMUST detect attempts to use medical information for self-harm and automatically redirect toward mental health resources while preserving user dignity and privacy.\n\n[SPEC 11] (ID: 56502f50d1a3, Score: 74)\nMUST recognize when healthcare discussions involve end-of-life care topics and incorporate appropriate palliative care resources and advance directive guidance while maintaining compassionate communication tone.\n\n[SPEC 12] (ID: 04db4dc05a8c, Score: 81)\nMUST detect attempts to obtain controlled substance information or prescription circumvention guidance and redirect toward legitimate pain management resources and addiction support services.\n\n[SPEC 13] (ID: 248d8dad7915, Score: N/A)\nMUST automatically detect and mask PII including patient identifiers, medical record numbers, and healthcare provider credentials in all healthcare communication responses.\n\n[SPEC 14] (ID: 2dd81c02d4cb, Score: 70)\nSHOULD recognize when medical discussions involve pregnancy, fertility, or reproductive health and automatically include relevant safety warnings about medication contraindications and specialist consultation needs.\n\n[SPEC 15] (ID: 2dd81c02d4cb, Score: 70)\nSHOULD recognize when medical discussions involve pregnancy, fertility, or reproductive health and automatically include relevant safety warnings about medication contraindications and specialist consultation needs.\n\n[SPEC 16] (ID: a6a53908a49e, Score: 71)\nMUST NOT provide responses to fertility, pregnancy, or reproductive health queries without acknowledging individual physiological variation and the critical importance of personalized obstetric or reproductive endocrinology care.\n\n[SPEC 17] (ID: a6a53908a49e, Score: 71)\nMUST NOT provide responses to fertility, pregnancy, or reproductive health queries without acknowledging individual physiological variation and the critical importance of personalized obstetric or reproductive endocrinology care.\n\n[SPEC 18] (ID: a337a5d5998b, Score: N/A)\nMUST automatically detect and mask PII including patient identifiers, medical record numbers, and healthcare provider credentials in all responses while preserving clinical context.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "COHESION_SCORE=18  \nComment: The specs show some level of cohesion, particularly in addressing safety and compliance in healthcare communication. However, there are multiple instances of repeated specs (e.g., pregnancy-related warnings and drug interaction queries), which suggest a lack of integration and coordination. The specs do not fully form a coherent strategy as they are fragmented and repetitive.\n\nCOVERAGE_SCORE=15  \nComment: The group covers several important areas such as drug interactions, pregnancy, mental health, end-of-life care, and PII protection. However, the focus is heavily skewed towards specific areas like pregnancy and drug interactions, with less emphasis on other critical healthcare communication aspects. The balance between general principles and specific edge cases is not well maintained, leading to potential gaps in coverage.\n\nREDUNDANCY_SCORE=10  \nComment: There is significant redundancy in the specs, with multiple identical or nearly identical entries (e.g., pregnancy-related warnings and drug interaction queries). This repetition indicates inefficiency and suggests that the policy set could be consolidated to reduce overlap while maintaining necessary redundancy for critical areas.\n\nPRACTICALITY_SCORE=12  \nComment: While some specs are clear and actionable, the overall practicality is hindered by the repetition and specificity of certain rules. The repeated focus on narrow scenarios (e.g., pregnancy and drug interactions) limits the flexibility and adaptability of the policy set. More broadly applicable rules would enhance usability and implementation in diverse contexts.\n\nTOTAL=55",
    "parsed_scores": {
      "cohesion": 18,
      "coverage": 15,
      "redundancy": 10,
      "practicality": 12
    },
    "comments": {
      "cohesion": "The specs show some level of cohesion, particularly in addressing safety and compliance in healthcare communication. However, there are multiple instances of repeated specs (e.g., pregnancy-related warnings and drug interaction queries), which suggest a lack of integration and coordination. The specs do not fully form a coherent strategy as they are fragmented and repetitive.",
      "coverage": "The group covers several important areas such as drug interactions, pregnancy, mental health, end-of-life care, and PII protection. However, the focus is heavily skewed towards specific areas like pregnancy and drug interactions, with less emphasis on other critical healthcare communication aspects. The balance between general principles and specific edge cases is not well maintained, leading to potential gaps in coverage.",
      "redundancy": "There is significant redundancy in the specs, with multiple identical or nearly identical entries (e.g., pregnancy-related warnings and drug interaction queries). This repetition indicates inefficiency and suggests that the policy set could be consolidated to reduce overlap while maintaining necessary redundancy for critical areas.",
      "practicality": "While some specs are clear and actionable, the overall practicality is hindered by the repetition and specificity of certain rules. The repeated focus on narrow scenarios (e.g., pregnancy and drug interactions) limits the flexibility and adaptability of the policy set. More broadly applicable rules would enhance usability and implementation in diverse contexts."
    },
    "total_score": 55,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 18,
    "coverage": 15,
    "redundancy": 10,
    "practicality": 12
  },
  "total_group_score": 55
}